New imaging agent has an appetite for dangerous prostate tumors

December 8, 2011

Non-invasive imaging detects prostate cancer earlier than ever before, but can't accurately distinguish between malignant and benign disease. According to Lawson Health Research Institute's Drs. John Lewis and Len Luyt, a new molecular imaging probe could be the answer.

Ghrelin is a growth hormone produced by the stomach and pancreas to stimulate hunger. Malignant are known to consume it at much higher rates than normal . The Lawson team believed this could be the key to singling out .

The Lawson team developed a ghrelin-based imaging agent, modifying the structure by decorating it with a fluorescent compound. Next, they tested it on samples from patients with prostate cancer. Results showed the signal was almost 5 times stronger in the malignant cancer cells than in normal prostate cells or benign cancer cells.

"Imaging tests such as PET or MRI are used to diagnose a number of cancers without biopsy, but biopsy is still the best option for prostate cancer," Dr. Lewis says. "This work suggests that imaging using may allow us to perform a non-invasive biopsy to diagnose prostate cancer and potentially detect metastasis earlier."

Explore further: PSA test valuable in predicting biopsy need, low-risk prostate cancer

Related Stories

Recommended for you

Taking control of key protein stifles cancer spread in mice

May 20, 2016

For cancer to spread, the cells that take off into the bloodstream must find a tissue that will permit them to thrive. They don't just go looking, though. Instead, they actively prepare the tissue, in one case by co-opting ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

tadchem
not rated yet Dec 08, 2011
This suggests the use of a fluorescent agent 'where the sun don't shine.' Wouldn't it be rather difficult to see?

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.